A Proposed Role for Lymphatic Supermicrosurgery in the Management of Alzheimer's Disease: A Primer for Reconstructive Microsurgeons
- PMID: 40083619
- PMCID: PMC11896717
- DOI: 10.1055/a-2513-4313
A Proposed Role for Lymphatic Supermicrosurgery in the Management of Alzheimer's Disease: A Primer for Reconstructive Microsurgeons
Abstract
The relatively recent discovery of a novel lymphatic system within the brain meninges has spurred interest in how waste products generated by neurons and glial cells-including proteins associated with Alzheimer's disease (AD) pathology such as amyloid beta (Aβ) and tau-are disposed of. Evidence is building that suggests disease progression in AD and other cognitive impairments could be explained by dysfunction in the brain's lymphatic system or obstruction of drainage. An interesting implication of this hypothesis is that, by relieving the obstruction of flow, lymphatic reconstruction along the drainage pathway could serve as a potential novel treatment. Should this concept prove true, it could represent a surgical solution to a problem for which only medical solutions have thus far been considered. This study is meant to serve as a primer for reconstructive microsurgeons, introducing the topic and current hypotheses about the potential role of lymphatic drainage in AD. A preview of current research evaluating the feasibility of lymphatic reconstruction as a surgical approach to improving Aβ clearance is provided, with the aim of inspiring others to design robust preclinical and clinical investigations into this intriguing hypothesis.
Keywords: Alzheimer's disease; glymphatic system; intramural periarterial drainage; lymphatic reconstruction; lymphovenous anastomosis; meningeal lymphatic system; supermicrosurgery.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).
Conflict of interest statement
Conflict of Interest J.P.H., W.F.C., and D.H.N. disclose that they have consulting relationships with MMI, Inc. Q.X. has no conflicts to disclose. J.P.H. is an editorial board member of the journal but was not involved in the peer reviewer selection, evaluation, or decision process of this article. No other potential conflicts of interest relevant to this article were reported.
Figures

References
-
- Kumar A, Sidhu J, Lui F, Tsao J W.Alzheimer DiseaseIn:StatPearlsAccessed November 20, 2024 at:https://www.ncbi.nlm.nih.gov/books/NBK499922/
-
- Ferrari C, Sorbi S. The complexity of Alzheimer's disease: an evolving puzzle. Physiol Rev. 2021;101(03):1047–1081. - PubMed
-
- Iaccarino L, Burnham S C, Dell'Agnello G, Dowsett S A, Epelbaum S. Diagnostic biomarkers of amyloid and tau pathology in Alzheimer's disease: an overview of tests for clinical practice in the United States and Europe. J Prev Alzheimers Dis. 2023;10(03):426–442. - PubMed
-
- Xie Q, Louveau A, Pandey S, Zeng W, Chen W F. Rewiring the brain: the next frontier in supermicrosurgery. Plast Reconstr Surg. 2024;153(02):494e–495e. - PubMed
LinkOut - more resources
Full Text Sources